Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with WVE: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
WVE
Wave Life Sciences Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
WVE
Wave Life Sciences Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
WVE: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only WVE
4
GSK
GSK
customer
TAK
Takeda Pharmaceutical
customer
—
Asuragen
unlisted
supplier
—
Takeda
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
customer
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
WVE, dashed
LLY
ELI Lilly & Co
Change
1,417.89
· pre 1,434.95
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
WVE
Wave Life Sciences Ltd.
Change
3.62
· pre 3.62
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$714.0M
Revenue
$13M
Q3 FY26
Revenue
$43M
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
LLY
ELI Lilly & Co
vs
WVE
Wave Life Sciences Ltd.
1,417.89
pre 1,434.95
delayed
Price
3.62
pre 3.62
delayed
$1.3T
Mkt cap
$714.0M
Q3 FY26
$24.4B
Revenue
$13M
Q3 FY26
FY25
$65.2B
Revenue
$43M
FY25
Change
Change
LLY
1,417.89
vs
WVE
3.62
Pre-market
Nov 5 '26
delayed